SPOTLIGHT -
Subclinical hypothyroidism may worsen metabolic health in PCOS patients
A new study reveals that polycystic ovary syndrome patients with subclinical hypothyroidism face greater risks of hormonal and metabolic imbalances.
Read More
Testing protocols and general prevalence of STIs during COVID-19
April is STI Awareness Month, and as such, we are focusing on testing and increase of STDs in the pandemic, especially how women and minorities are affected.
Listen
Drospirenone found to ease menstrual symptoms
A recent study highlights the effectiveness of drospirenone with estetrol in significantly reducing physical and emotional menstrual symptoms, especially among new hormonal contraceptive users.
S3E2: HPV and cervical cancer with Sangini Sheth, MD, MPH
On this episode of Pap Talk, Sangini Sheth, MD, MPH discusses the latest research in cervical cancer and HPV.
Placebo pills found to significantly reduce premenstrual syndrome symptoms
A new study found that open-label placebos can effectively reduce the intensity and interference of premenstrual syndrome symptoms, even when patients know they are taking a placebo.
Study highlights how PCOS alters uterine lining
A recent study found that polycystic ovary syndrome affects uterine cell composition and gene expression, shedding light on fertility challenges and potential treatment targets.
